# Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer

> **NCT00005055** · PHASE2 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 39 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** glufosfamide

## Key facts

- **NCT ID:** NCT00005055
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2001-03
- **Final completion:** —
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005055, "Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00005055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*